is to maintain normoglycaemia, as hypoglycaemia deprives the brain of substrate for respiration and causes cerebral damage similar to that caused by hypoxia. Intravenous dextrose together with glucagon is the traditional method of treating hypoglycaemia and, if cerebral oedema occurs, intramuscular dexamethasone and intravenous mannitol may be used. When a large dose of depot insulin has been injected, as in our patient, there may be difficulty in maintaining normoglycaemia, especially if excessive alcohol has been drunk and little carbohydrate ingested, as even modest amounts of alcohol may delay recovery from hypoglycaemia by inhibiting gluconeogenesis. Glucagon is ineffective if there are no hepatic glycogen stores. In our patient excising the injection site appeared to remove the bulk of the depot insulin, thus preventing continued absorption of insulin from the injection site. To our knowledge this is the first report of the procedure being carried out in such patients. The procedure may be more valuable after administration of long-acting rather than soluble insulin, since with soluble insulin rapid diffusion from the injection site would be expected. We have examined the potential for single-drug treatment in epilepsy by prospective studies in previously untreated patients referred to a neurological department.2 3 We report and compare the chronic metabolic effects on two groups of patients treated for two years with phenytoin or carbamazepine.
Patients, methods, and results
We studied two groups of previously untreated patients with tonic-clonic or partial seizures, or both. Group 1 consisted of 30 patients (14 male, 16 female; median age 26 years, range 13-62 years), who were treated with phenytoin alone. Group 2 comprised 33 patients (17 male, 16 female; median age 28 years, range 8-68 years) treated with carbamazepine alone. All patients were followed prospectively with regular monitoring of drug concentrations.2 No other drugs were administered during the study.
All elsewhere on the basis of our clinical studies that there is much undesirable and unnecessary polypharmacy in the treatment of epilepsy.3 Prolonged follow-up will be of interest, but the present findings are in keeping with our view that the incidence of chronic toxicity can be reduced by careful monitoring of single-drug treatment.
Collapse of cervical spine treated by Down's Ace mark III halo assembly
Treating patients with collapse of the cervical spine by applying Down's Ace mark III halo assembly is suitable only in terminal patients in whom pain has become intolerable and paraplegia threatens. When the secondary deposits are so widespread the prognosis is usually bleak, and radiation and chemotherapy have only a delaying action on the final result. With this degrge of destruction of the vertebrae pain is intolerable, and the rigid support afforded by the halo effectively abolishes this and allows a person without paraplegia to be mobilised.
Case report
A 35-year-old woman was first seen in March 1975 for a breast lump that had been present for four years. Simple mastectomy and biopsy of the lump and the right axillary glands were carried out and showed a scirrhous carcinoma with spread to the axillary glands. A bone scan showed no abnormality, and she was referred for high-dose radiation (total 4000 rads). In July 1977 a nodule in the upper part of the right breast proved to be a recurrence, and by February 1978 there were palpable fixed glands in the axilla. Tamoxifen 20 mg twice daily was started.
In December 1979 she fell downstairs and complained of neck pain. Radiography showed the body of the second cervical vertebra to be badly eroded. As a temporary measure the cervical spines of the second and third cervical vertebrae were wired together. This relieved the pain with the aid of a cervical collar until April 1981. After the wiring a further course of radiation was given.
Her condition continued to deteriorate, and from July 1980 to July 1981 she was given eight courses of fluoracil 500 mg intravenously and vincristine 1 mg intravenously at weekly intervals for four weeks. Nandrolone decanoate 50 mg intramuscularly was given twice during the four-week course, and prednisolone 10 mg twice daily was given over two weeks. By September 1981 she was in acute pain, which was relieved only by cervical traction in the horizontal position. Any movement was extremely painful. Radiography showed destruction of the upper three cervical vertebrae.
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Halo apparatus in position.
The halo apparatus was applied in October under local anaesthesia (figure). With this apparatus she was able to sleep and to walk the length of the corridor. This was of considerable benefit, and she died in her sleep in November 1981.
Comment
Kevin and Harrington' recently used methylmethacrylate to replace vertebral bodies and stabilise fracture dislocations of the spine caused by metastatic malignant disease. They stated: "The reader must be cautioned against over zealous application of the technique to all patients with vertebral involvement by metastatic lesions. The vast majority of symptomatic vertebral lesions can be controlled by local irradiation alone. Most of the vertebrae that subsequently collapse do not cause neural impingement and will become asymptomatic with a combination of local radiotherapy and temporary external support."
Only rare cases will be suitable for treatment by this technique. When the cervical spine is affected the halo apparatus offers pain relief by a fairly painless and simple method. 
